US FDA approves GSK’s HIV drug for patients with limited options

This post was originally published on this site

(Reuters) – The U.S. Food and Drug Administration on Thursday approved GlaxoSmithKline Plc’s HIV drug, Rukobia, to treat adult patients who have run out of treatment options. The oral treatment from the company’s HIV unit, ViiV Healthcare, has been …

Click here to read full article